ONCOIMMUNIN Trademark

Trademark Overview

On Thursday, March 29, 2001, a trademark application was filed for ONCOIMMUNIN with the United States Patent and Trademark Office. The USPTO has given the ONCOIMMUNIN trademark a serial number of 76231991. The federal status of this trademark filing is REGISTERED AND RENEWED as of Wednesday, December 25, 2013. This trademark is owned by OncoImmunin, Inc.. The ONCOIMMUNIN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

molecular analysis, development and research services for others; and consulting services for others regarding molecular development
oncoimmunin

General Information

Serial Number76231991
Word MarkONCOIMMUNIN
Filing DateThursday, March 29, 2001
Status800 - REGISTERED AND RENEWED
Status DateWednesday, December 25, 2013
Registration Number2873110
Registration DateTuesday, August 17, 2004
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 25, 2004

Trademark Statements

Goods and Servicesmolecular analysis, development and research services for others; and consulting services for others regarding molecular development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 10, 2001
Primary Code042
First Use Anywhere DateMonday, February 28, 1994
First Use In Commerce DateFriday, September 30, 1994

Trademark Owner History

Party NameOncoImmunin, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20877
Party NameOncoImmunin, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20877
Party NameOncoImmunin, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20877

Trademark Events

Event DateEvent Description
Tuesday, February 27, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 27, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 27, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 17, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, May 15, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, May 15, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 15, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 15, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, May 15, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, December 25, 2013NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, December 25, 2013REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, December 25, 2013REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, December 13, 2013REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Wednesday, December 25, 2013CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, December 13, 2013TEAS SECTION 8 & 9 RECEIVED
Thursday, November 18, 2010REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, November 18, 2010CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, November 4, 2010TEAS SECTION 8 & 15 RECEIVED
Thursday, May 7, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 17, 2004REGISTERED-PRINCIPAL REGISTER
Tuesday, May 25, 2004PUBLISHED FOR OPPOSITION
Wednesday, May 5, 2004NOTICE OF PUBLICATION
Thursday, March 11, 2004APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 23, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 26, 2004CASE FILE IN TICRS
Monday, February 23, 2004FAX RECEIVED
Tuesday, November 4, 2003LETTER OF SUSPENSION MAILED
Wednesday, November 7, 2001USE AMENDMENT ACCEPTED
Monday, October 22, 2001AMENDMENT TO USE PROCESSING COMPLETE
Monday, June 11, 2001USE AMENDMENT FILED
Friday, June 15, 2001LETTER OF SUSPENSION MAILED
Tuesday, June 12, 2001ASSIGNED TO EXAMINER

Related Keywords

oncoimmunin services others molecular development regarding consulting research analysis